Hydrix Limited (ASX: HYD), an Australian technology company specialising in multidisciplinary engineering and technology investment across medical technology, defence, industrial, and mining, has announced a significant multi-year contract for its wholly owned subsidiary, Hydrix Medical Pty Ltd. Hydrix Medical, which focuses on sourcing and distributing breakthrough cardiovascular technologies, has secured an agreement with the National Heart Centre Singapore (NHCS). This contract involves the deployment of the Implicity™ cloud-based remote cardiac monitoring platform, with an estimated value of A$0.625 million over three years, contingent on patient volumes.
The agreement is projected to yield annual recurring revenue of approximately A$0.21 million over its three-year term. Under the contract, NHCS will implement the Implicity platform for the remote monitoring of patients with Cardiac Implantable Electronic Devices (CIEDs), including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronisation therapy devices. The platform aggregates and standardises data from all major device manufacturers into a unified interface, aiming to enhance workflow efficiency for clinicians and facilitate earlier intervention through advanced analytics.
Implementation of the platform is expected to commence shortly, with cloud deployment delivered by Implicity and Hydrix Medical. Revenue for Hydrix will commence upon this implementation. The contract positions NHCS, one of Asia’s leading cardiac hospitals, as a key reference customer, supporting Hydrix Medical’s expansion strategy. Vickie Edwards, Director Sales & Operations at Hydrix Medical, stated, “Securing National Heart Centre Singapore as a customer is a significant commercial milestone for Hydrix Medical and an important validation of our Asia-Pacific growth strategy.” She highlighted that NHCS’s selection demonstrates the growing need for scalable digital health solutions. Hydrix intends to leverage this partnership for further opportunities across Singapore, Australia, and the broader Asia-Pacific region.
